Bonum Certa Men Certa

EPO: Give Us Low-Quality Patent Applications, Patent Trolls Have Use for Those

The race to the bottom continues at the EPO, which is happy to grant loads of invalid (i.e. fake, bogus) patents in defiance of the law (EPC)

EPO delivery



Summary: What good is the EPC when the EPO feels free to ignore it and nobody holds the EPO accountable for it? At the moment we're living in a post-EPC Europe where the only thing that counts is co-called 'products' (i.e. quantity, not quality).

THE number of applications for European Patents is decreasing. We took note of it earlier this year. Maybe there's a growing number of businesses and individuals who realise that European Patents are nowadays overpriced and overvalued. A lot of them are bogus. They're worse than worthless and it wasn't always like that.



"It's very clear that the EPO's management is nowadays in bed with patent maximalists; it works for these parasitic firms and opportunists instead of for science and technology. It doesn't even work for Europe!"Misleading and bad advice from the European Patent Office (EPO) said this earlier this week: "Even minor technical improvements can meet a market need and be worth patenting. That's one conclusion of our SME case studies."

They're still googlebombing the term "SME" (or "SMEs") every other day, on average. Also notice the use of the word "minor". They just want lots of applications and grants (of fake patents). On the same day the EPO again advertised its partnership with patent trolls' front groups. "How do you implement a sustainable IP management system? Our experts will tell you at this event," it wrote about its event with LESI. Shameful. It's very clear that the EPO's management is nowadays in bed with patent maximalists; it works for these parasitic firms and opportunists instead of for science and technology. It doesn't even work for Europe!

"This is sadly becoming rather common and it’s very expensive."The abundance of fake European Patents is becoming a serious peril and a stain on Europe. IP Law Galli's Cesare Galli had this article promoted/disseminated through Lexology the other day, under the headline "Supreme Court of Cassation reverses patent limitation decision," and it said that "Supreme Court of Cassation [France, where António Campinos and Benoît Battistelli are from] recently reversed a Milan Court of Appeal ruling on patent limitation." Wikipedia says it is "one of the four courts of last resort in France. It has jurisdiction over all civil and criminal matters triable in the judicial system, and is the supreme court of appeal in these cases. It has jurisdiction to review the law, and to certify questions of law, to determine miscarriages of justice. The Court is located in the Palace of Justice in Paris."

Here's what happened (added emphasis/highlight is ours):

On 14 August 2019 the Supreme Court of Cassation (Decision 21402) reversed a Milan Court of Appeal ruling on patent limitation. The Supreme Court of Cassation found that although the Milan Court of Appeal had held the patent at issue to be valid, it had not granted the patentee's claims for infringement because the patent had been subject to a limitation procedure and the acts of infringement had been carried out before the application for limitation had been filed. As a result, the Supreme Court of Cassation granted the appeal and ruled as follows:

[...]

The same reasoning applies – as the Supreme Court of Cassation made clear in the grounds for its ruling – considering that the pronoun 'it' at the beginning of the last sentence refers unequivocally to the noun 'decision' in the previous sentence. This clarifies that only the European Patent Office's (EPO's) decision takes effect from the publication of a decision, whereas the subject matter of a decision (ie, the limitation) and, therefore, the text of the claim as amended in the limitation procedure under Article 105b of the European Patent Convention, produces its effects from the beginning of a patent's life, which is logical, because it is a limitation (ie, a measure that reduces rather than extends the scope of a patent's protection).

In view of these rules, it is therefore unquestionable that the Milan Court of Appeal's ruling (which the Supreme Court of Cassation reversed) had not been decided in accordance with the law, as the court of appeal had held that, until the date of acceptance of the EPO's proposed limitation, the patent in question was null and void in its entirety, even for the scope of protection confirmed by the limitation itself.


This is sadly becoming rather common and it's very expensive. Law firms pocket a lot of money from these needless disputes. They just want patents on everything. Why? Not because it's just or because it's good for science; it's just good for lawyers, it causes chaos and incurs legal bills. These crazy people have gone as far as actively promoting patents on thoughts, maths, life and nature. Chemical giants (poison/toxins such as pesticides and herbicides) nowadays claim to have a monopoly on plants and seeds!

Incidentally, replying to something said the other day and quoted here in the context of patents on nature/life, "Save the world" then commented to say he/she "agreed on the idea of not 'banning' CRISPR, but the relationship between regulations, science and allowing patents on something is a complex one, which to an extent has to be driven by restraint and caution, and not allowing huge agro companies doing whatever they want to. All the potential abuses and things that can go wrong need to be considered beforehand. All major technology has unforeseen consequences, and one great thing about the EU position on CRISPR is that it forces a debate on why it should be considered safe. The 'certain scenarios' you talk about could be wiping out indigenous species, changing the economics of local agriculture, and furthering the interests of Western companies in the developing world. How to balance these risks is complicated and must require caution..."

"Law firms pocket a lot of money from these needless disputes."Debate about patents on life has become one about the harms of GMO -- a subject we covered here regularly about a decade ago. "SlightlyDoubtful" then added: "Which confirms my initial thinking that the technology is not as precise as is made out by the article, to the extent that off-target nuclease mediated mutations are part and parcel of the technology, but then to what extent do these events occur in plants, and which known effects (beneficial or nefarious) of such off-target modifications have been described ? Whilst I agree that it seems highly unlikely that joe public will go around injecting itself with transformed plant DNA (although these days, one never knows), it is undeniable that the release of transformed regenerated plant lines into the wild using a genetic manipulation tool that has the capability to create unwanted genetic side effects is no different to the current issues with GMO plants in general, and the article glosses over this point. The question then, is whether the GM plant industry has shown itself to be better capable of explaining, and being transparent, to the public (including commissioners, MEPs and regulators) with regard to all of the potential downsides linked to the usage of this particular tool. When I worked in that industry, it simply wasn't up to the job in general, with the result that no matter how good the molecular tool or production platform a given entity might have, if the industry can't communicate correctly to the public and the authorities, then sentiment will turn against it and adoption will remain the preserve of academics."

Patents on life have long motivated people to protest in front of the EPO. There are also protests against patents on life-saving medicine, which brings about ethical dilemmas. Yesterday we saw Auris Medical bragging about patents up your nose in a paid press release that said "a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for its patent application entitled “Pharmaceutical Composition Comprising Betahistine” (U.S. Patent Application No. 15/887,388). In addition, the Company received an “Intention to Grant” notice from the European Patent Office (EPO) for its related patent application entitled “Intranasal Composition Comprising Betahistine” (European Patent Application 18 703 749.4). Upon issuance, the patents are expected to expire no earlier than February 2038 and will provide key intellectual property protection for the Company's intranasal betahistine program."

"This is what happens when the EPO wrongly pursues the goals of patent maximalists."SWNS Stories wrote about the EPO grappling with the "hey hi" hype (and computer/automatically-generated patent applications). To quote: "A team of academics from the University of Surrey has filed the first ever patent applications for AI-created inventions. That means no human inventor contributed to the development of the invention, and the patent applications are under the name of the AI inventor – DABUS. DABUS (Device for Autonomous Bootstrapping of Unified Sentience) is the creation of Stephen Thaler, a pioneering AI researcher based in Missouri. According to the Financial Times, Mr Thaler taught DABUS to produce ever more complex items using words and images. [...] Both the UKIPO and the European Patent Office (EPO) accept that the inventions made by DABUS are eligible to receive a patent. In simple terms, this means that the light device and the container are considered to be industrially applicable and brand-new inventions. However, the fact that the inventions are not the product of human development opens up a whole new world for patents. For example, it remains unclear who (or what) will be credited as the owner or holder of the patent, should it be granted. There are no laws in any country in the world to specify how cases like this should be dealt with. And while AI has been on the global radar for decades as the future of creativity, there is no precedence for an AI machine to be granted a patent or to be credited as an inventor."

This is what happens when the EPO wrongly pursues the goals of patent maximalists. Maybe one day the number of these computer-generated patent applications will exceed that of legitimate (human-made) applications, whereupon the whole legitimacy of this system can collapse. Just like in the financial markets where algorithms nowadays account for the lion's share of transaction volume. It's gamed and rigged.

Recent Techrights' Posts

Slopwatch: Brian Fagioli, Google News, and Other LLM Slopfarms
Why does Google News keep promoting these fake articles?
Links 29/10/2025: Amazon Kept "Data Center Water Use Secret", "Abuse of Power" Against Media
Links for the day
Gemini Links 29/10/2025: "My Hardware Specs" and "Goodbye Debian…"
Links for the day
EPO Cocainegate: Feedback and Clarifications
Part III will come out soon
Links 29/10/2025: "US Military Is Destroying the Planet Beyond Imagination" and Boat Strikes Deemed Unlawful
Links for the day
Quality Comes First (Techrights Search)
It's generally working already, but we wish to polish it some more
Techrights Party Countdown
Late next week we'll be holding a party near our home
European Parliament and Council Directive on Privacy is Vanishing
"edited / censored some time more recently"
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Tuesday, October 28, 2025
IRC logs for Tuesday, October 28, 2025
Slopwatch: The March of Slopfarms, From UbuntuPIT to Linux Journal and to Various Fake Sites Still Promoted by Google News
It's so worrying to see what the Web has become
Links 29/10/2025: CISA, Ukraine, and Amazon Problems
Links for the day
[Teaser] The EPO's Spokesperson, a Cocaine User, Fancies Young Women
How's that for "optics" in the EU and Europe's second-largest institution?
How Will António Campinos Respond to the EPO's 'Cocainegate'?
That's the same thing we saw and still see when the press deals with enablers and partners of Jeffrey Epstein
Join Us Now and Share the News - Part IV: There Cannot be Free Software Without Free Press and Free Information
One day, one can hope, more people will recognise that for Software Freedom we need free press and free thinkers
Join Us Now and Share the News - Part III: Principled Stance Is Never Cheap
Protecting the truth and insisting that the general public is made aware of things that really happened isn't cheap
Join Us Now and Share the News - Part II: Because Scarcity of Accurate Information Breeds Collective Ignorance
we too will strive to share information that's aggressively suppressed
Gemini Links 28/10/2025: More New Arrivals at Geminispace, xkcd on "Document Forgery"
Links for the day
Join Us Now and Share the News - Part I: Defence of the Truth
This year we make a very strong, firm statement for truth, even if that means explaining our work to the top media judge in the country
Links 28/10/2025: Meta and Fentanylware (CheeTok) Age-Restricted Down Under, "Britain Needs China’s Money"
Links for the day
Links 28/10/2025: Mass Layoffs at Amazon and Charter to Cut 1,200 Jobs
Links for the day
The Cocaine Patent Office - Part II: The Person Who Planted Paid-for Fake News for the European Patent Office (EPO) is a Cocaine User, Friend of António Campinos, Now on Record as Having Been Arrested
Background: High-level manager at the European Patent Office caught in public with cocaine, arrested
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Monday, October 27, 2025
IRC logs for Monday, October 27, 2025
Google News Drowning in Slop (and Slopfarms That Hijack About Half the Results)
Google News seems to be drowning in this stuff
Gemini Links 28/10/2025: "How to Maximize Your Positive Impact" and ASCII Art and Artist Attribution
Links for the day
PETA and Activism
Being staff or volunteer in PETA isn't easy
Big Blue, Huge Debt
debt will soar again
Links 27/10/2025: Mass Surveillance Sold as "AI", People Reluctant to Lose Physical Media
Links for the day
Parties and Milestones Again
we've begun putting up about 40 balloons
Techrights' 19th Anniversary: Bronze
Time to go back to preparing for this anniversary
Our Latest European Patent Office (EPO) Series Will Last Several Weeks, Will Ask the EPO Management and the European Union (EU) Very Difficult Questions
If nobody loses a job (or jobs) over this, then the EU basically became no better than Colombia or Nicaragua
Slopwatch: LinuxSecurity, UbuntuPIT, Brian Fagioli, and Google News
We focus on stories that are fake or LLM slop that disguises itself as "news" about Linux
Links 27/10/2025: Wikipedia Vandalism, Bruce Perens Opens up on Childhood
Links for the day
This Site Could Not be Done by LLMs Even If It Wanted to (Because It's Not a Parrot of What Other Sites Say)
LLMs have no knowledge or deep understanding
Microsoft is Disloyal Towards Its Most Loyal Employees
Against its most faithful enablers
19 Years, No Censorship
No factual information is ever going to be removed, more so if it is in the public interest
We Are Not a Conventional Site, That's Why They Hate (or Love) Us
Throughout the week this week we'll be focusing on the EPO
Following the Line of Cocaine All the Way to the Top
Even a million denials and spin-doctoring won't distract from the core issue
The Cocaine Patent Office - Part I: António Campinos Brought Corruption and Nepotism to the EPO, Then Came the Cocaine
High-level manager at the European Patent Office (EPO) caught in public with cocaine, the Office has some answering to do
Purchasing/Possessing Computers Isn't the Same as Controlling Computers
Let's strive to put computers back under the control of their users, no matter who purchased these (usually the users)
Gemini Links 27/10/2025: Alhena 5.4.3 and Fixing Bash
Links for the day
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Sunday, October 26, 2025
IRC logs for Sunday, October 26, 2025
Thankfully We've Made Copies of More Interesting Data From statCounter
If statCounter (the Web site or the 'webapp') vanished overnight, we'd still have something left of it
More Silent Layoffs at IBM/Red Hat
when the media counts such layoffs or presents tallies the numbers are very incomplete